title: [Cardiopulmonary capacity in patients before and after prosthetic valve replacement].
abstract: In this study we wanted to investigate if noninvasive cardiopulmonary exercise testing can be securely, accurately applied in patients with acquired cardiac valve disease pre- and postoperatively with any convenience. Furthermore, we looked if the cardiopulmonary exercise capacity (anaerobic threshold, etc.) was improved postoperatively (3 and 6 months) in 15 patients suffering from severe mitral valve disease as compared to the preoperative condition. The symptom-limited cardiopulmonary exercise testing was performed on a bike in a semi-supine position using a ramp program (+20 W/min). The following parameters were continuously monitored, and the breath-by-breath gas exchange values documented: cardiocirculatory parameters (heart rate; blood pressure; surface ECG; exercise capacity in Watts); gas-exchange parameters (O2-uptake VO2; CO2-production VCO2; respiratory anaerobic threshold VO2 AT; gas-exchange ratio VCO2/VO2; O2-pulse VO2/HR; aerobic capacity delta VO2/delta WR) and ventilatory parameters (respiratory rate; tidal volume Vt; minute ventilation VE; equivalent for O2: VE/VO2 and CO2: VE/VCO2). The 155 cardio-pulmonary exercise tests in 115 patients were practicable, safe (no emergency case) and accurate. In 100 patients late postoperatively (68.3 +/- 53.0 -102.9 +/- 41.2 months) after aortic or mitral valve replacement or both without signs of significant hemolysis or prosthetic valve dysfunction the NYHA classification was too imprecise to characterize the actual exercise capacity of the patients (e.g., NYHA class II: Weber class B to E). Patients with aortic valve prosthesis had a significantly better anaerobic threshold (57.4 +/- 19.1% pred. value max. VO2) as compared to those with mitral valve replacement (mean: 35.9% pred. value max. VO2).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Klinik III für Innere Medizin der Universität zu Köln.
authors.forename: U J
authors.initials: UJ
authors.lastname: Winter
authors.forename: M P
authors.initials: MP
authors.lastname: Sedlak
authors.forename: A K
authors.initials: AK
authors.lastname: Gitt
authors.forename: J
authors.initials: J
authors.lastname: Fritsch
authors.forename: H J
authors.initials: HJ
authors.lastname: Deutsch
authors.forename: P G
authors.initials: PG
authors.lastname: Berge
authors.forename: H H
authors.initials: HH
authors.lastname: Hilger
authors.forename: M
authors.initials: M
authors.lastname: Südkamp
authors.forename: E R
authors.initials: ER
authors.lastname: de Vivie
mesh_terms: D000328:Adult; D000368:Aged; D001021:Aortic Valve / Q000503:physiopathology / Q000601:surgery; D005080:Exercise Test; D005260:Female; D005500:Follow-Up Studies; D006333:Heart Failure / Q000503:physiopathology / Q000601:surgery; D006349:Heart Valve Diseases / Q000503:physiopathology* / Q000601:surgery; D006350:Heart Valve Prosthesis; D006439:Hemodynamics / Q000502:physiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve / Q000503:physiopathology / Q000601:surgery; D011183:Postoperative Complications / Q000175:diagnosis / Q000503:physiopathology*; D011474:Prosthesis Design; D011659:Pulmonary Gas Exchange / Q000502:physiology*; D013147:Spirometry
vernacular_title: Kardiopulmonale Leistungsfähigkeit bei Patienten vor und nach prothetischem Klappenersatz.